summary
Commentary
This comprehensive review assesses the outcome of six to 12 sessions of EMG biofeedback from the masseter muscle alone or in combination with stress management for TMD. Three outcome-categories (global improvements, reported pain and clinical examinations) were evaluated in patients of typical age-and sex-distributions for TMD. More than half of the patients had failed to improve with previous conservative treatment. Substantial improvements, particularly in pain, were to be found about twice as often as in placebo or in no-treatment control groups, and these improvements remained at long-term followup. The variation in improvement was great, although treatment results are in line with those of several other conservative interventions for TMD.
As the authors point out, TMD embraces a heterogeneous group of clinical problems and the etiology is not well understood. The analysis includes 2 decades of research and the diagnostic concepts have varied over time. Criteria for inclusion or exclusion in the studies have also varied, therefore. Little is known about what characteristics make patients more suitable for the treamtent method.
In general, the intervention aims at reducing muscular activity in frequency, intensity and/or duration, in individuals who have myofacial pain. The significance of the commonlyembraced etiological concept of muscular hyperactivity has been questioned. An attractive quality with EMG biofeedback is that it objectively measures the variable that it is supposed to change. Although a reduced EMG activity can be observed within sessions, no study has shown a reduction over time. Moreover, subjective or clinical pre-to post-treatment improvements have not correlated well with EMG data. Alternative hypotheses have therefore been advanced and are discussed thoroughly by the authors. One theory suggests that biofeedback enhances awareness of muscular activity in general and thereby leads to increased control and less parafunctional activity, which is possible but not proved. Another suggestion is that the patients perceptions of control, not their actual abilities to control, are altered and result in improved coping and selfefficacy. Cognitive changes are thus also a possibility.
The superiority of any particular conservative treatment approach over another in TMD has seldom been proved. Biofeedback is a reversible and safe method, in line with many treatment recommendations for TMD, but is it efficient? Even if the authors' conclusions about positive treatment efficacy are correct, the mechanisms behind them remain unexplained.
